Click Here to return To Results

 

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003 See this aricle in Pubmed Article Abstract In high-risk patients with atrial fibrillation, fixed-dose oral ximelagatran was at least as effective as well-controlled warfarin for prevention of stroke and systemic embolism.

Related Tags

(click to filter results - removes previous filter) advances in neurology anticoagulant,complications of anticoagulant,treatment anticoagulant,treatment in CVD atrial fibrillation atrial fibrillation,nonvalvular cerebrovascular accident cerebrovascular accident,prevention of coumarin liver function enzymes prevention of neurologic disorders serum alanine aminotransferase thrombin inhibitor treatment of neurologic disorder ximelagatran

Click Here to return To Results